Supaveda · Formula Spotlight — A First in This Series
Dashamoola
दशमूल — The Ten Roots · Ayurveda's Master Anti-Inflammatory Formula
Dasamoola · Dashamool · Dashamula · Ten-Root Decoction · Brihat+Laghu Panchamoola · Shvayathuhara Gana
Every previous herb in this series has been a single plant. Dashamoola is different. It is Ayurveda's most important polyherbal formula — a precisely assembled team of ten roots designed to accomplish together what no individual root could achieve alone. Understanding Dashamoola means understanding something fundamental about how classical Ayurvedic pharmacology works: not the search for a single "active compound," but the engineering of synergistic therapeutic ecosystems.
The name is transparent: Dasha (ten) + Moola (root). The formula comprises the roots of ten specific medicinal plants — five large trees and shrubs forming the Brihat Panchamoola (Large Five Roots), and five smaller plants forming the Laghu Panchamoola (Small Five Roots). Charaka, in the Charaka Samhita's systematic classification of therapeutic plant groups (Mahakashaya), listed this formula under Shvayathuhara Gana — the pharmacological group whose primary action is reducing inflammation and swelling (Shotha). It is the drug of choice — Shothe Dashamoola — in Charaka's explicit recommendation. 1 Modern pharmacological validation has confirmed this classification: published studies demonstrate anti-inflammatory activity comparable to aspirin, analgesic effects in validated pain models, and anti-platelet activity — all measured as a combination, as the formula was designed to be used. 2
to Aspirin.
All ten together.
🌿 Formula Intelligence — Why Ayurveda Assembled a Team of Ten, Not One
Every pharmaceutical model in modern medicine seeks the single active compound — isolate it, patent it, standardise it. Ayurveda took the opposite approach three millennia before pharmacology existed as a discipline: assemble multiple compounds with complementary mechanisms into a formula where each component addresses a different aspect of the target condition, and where the combined effect exceeds what any individual herb could provide. Dashamoola is the clearest demonstration of this principle. 1
Charaka's genius was in the architecture of the formula. The Brihat Panchamoola (large five) — Bilva, Agnimantha, Shyonaka, Patala, Gambhari — are roots from mature trees and large shrubs, characterised by structural firmness and grounding properties. They address the deep tissue dimensions of Vata disorder: bones (Asthi), joints (Sandhi), and the musculoskeletal framework. The Laghu Panchamoola (small five) — Shalaparni, Prishnaparni, Brihati, Kantakari, Gokshura — are roots from smaller, more delicate plants, characterised by penetrating, mobile, and channel-clearing properties. They address the functional dimensions: nerve pathways (Nadi), respiratory channels (Pranavaha Srotas), fluid channels (Mutravaha Srotas), and subtle tissue communications. Together the ten roots span the full range of Vata's functional territory — the nervous system, musculoskeletal system, respiratory system, and the fluid channels — producing a formula that is simultaneously anti-inflammatory, analgesic, bronchodilatory, nervine, diuretic, and tissue-nourishing. This multi-system coverage is why Dashamoola appears in more different Ayurvedic preparations and conditions than almost any other formula in the classical pharmacopoeia.
Modern network pharmacology is beginning to validate this design logic. A 2025 ScienceDirect network pharmacology analysis of Dashamoola's molecular mechanisms (Kumar RCS et al.) mapped the formula's compounds against known inflammatory and pain pathways, confirming that the ten roots collectively target a broader network of molecular nodes than any individual root — a computational validation of the classical observation that the formula's power is an emergent property of its combination, not reducible to any single constituent. 3
The Ten Roots — Brihat & Laghu Panchamoola
Dashamoola — The Complete Ten-Root Formula Architecture
The pharmacological balance of the formula is deliberate: nine of the ten roots have heating (Ushna) potency, countering Vata's cold quality. The tenth — Gokshura — is cooling (Sheeta), tempering the formula's overall heat to prevent Pitta aggravation and ensure the formula is genuinely Tridoshahara (balancing all three doshas) rather than simply heating. This single cooling counterbalance is the kind of pharmacological precision that distinguishes classical Ayurvedic formula design from simple additive herb combinations.
At a Glance — Key Evidence-Backed Benefits of the Formula
Traditional Ayurvedic Uses
Dashamoola is documented in the Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Sahasrayogam, Sharangdhara Samhita, and virtually every major classical Ayurvedic text. It appears in Charaka's fifty pharmacological classification groups (Gana) under Shvayathuhara Gana (Charaka's anti-inflammatory group), where it is designated the primary drug of choice for Shotha (inflammation and swelling). Its classical title is also Vataghna Mahakashaya — the supreme Vata-destroying formula — acknowledging its unmatched position as the foundational treatment for all conditions rooted in Vata aggravation. 1
The formula's versatility across systems is remarkable and pharmacologically explicable: Vata governs the nervous system, musculoskeletal movement, respiratory function, colon, urinary system, and all movement in the body. A formula that pacifies Vata comprehensively — as ten synergistic roots together do — will therefore benefit all conditions where Vata derangement is the primary or contributing pathophysiology. This explains why Dashamoola appears as a component in dozens of classical compound formulas: as Dashamoola Taila (oil for external application), Dashamoola Ghrita (medicated ghee), Dashamoola Kashayam (decoction), Dashamoolarishta (fermented decoction), and as the base for Basti (therapeutic enema) preparations — the most important Vata-pacifying Panchakarma treatment in classical Ayurveda. 1
The formula's special role in Sutika Paricharya (postpartum care) is one of its most well-validated classical applications. Childbirth is described in Ayurveda as a state of profound Vata aggravation — the body is depleted (Kshaya), dried (Ruksha), exhausted, and cold. Dashamoola is the classical first medicine given to a new mother from the day of delivery: the multi-root formula simultaneously manages postpartum pain (episiotomy, after-pains, back pain), supports uterine involution, addresses the inflammatory response of the birth wound, and begins the process of tissue regeneration and Vata pacification that classical texts prescribe for the full six-week postpartum recovery period. 4
Ayurvedic Properties (Formula-Level)
Classical Conditions and Uses
- Inflammation and swelling (Shotha) — the primary classical indication; the drug of choice in Charaka's Shvayathuhara Gana; acute and chronic inflammatory conditions across all systems
- Vata disorders (Vatavyadhi) — the primary Vata-pacifying formula; arthritis, joint pain, stiffness, nerve pain, musculoskeletal degenerative conditions, paralysis, tremors
- Rheumatoid arthritis (Amavata) — the primary classical anti-rheumatic formula; addresses both the inflammatory (Pitta) and degenerative (Vata) dimensions of joint disease
- Respiratory disorders (Shwasa, Kasa) — bronchial asthma, chronic cough, bronchitis; Kantakari bronchodilator, Brihati expectorant, Shalaparni nervine respiratory stabiliser
- Postpartum care (Sutika Paricharya) — the gold-standard classical postpartum formula; all four types of postpartum pain; uterine involution support; tissue regeneration after delivery
- Nervous system disorders — neuropathy, neuralgia, cervical spondylosis, sciatica; nervine tonic roots Shalaparni and Prishnaparni; Vata-channel clearing through the ten-root action
- Fever (Jwara) — antipyretic action; used in Shadangodaka alongside Mustha for fever management; anti-inflammatory fever reduction
- Abdominal pain and digestive disorders — Anaha (Vata-type constipation and bloating), abdominal distension, colic; Bilva's gut-soothing colon action
- Urinary disorders (Mutrakriccha) — Gokshura's diuretic and nephroprotective action; uric acid elimination; urinary stone prevention
- Panchakarma Basti — Dashamoola decoction is the most widely used base for Niruha Basti (decoction enema), the primary therapeutic procedure for Vata disorders in classical Panchakarma practice
How Dashamoola Works — The Formula's Pharmacological Architecture
The formula's mechanism is necessarily multi-pathway — ten roots, each contributing distinct phytochemical classes (flavonoids, alkaloids, saponins, glycosides, tannins, terpenoids), all converging on shared therapeutic targets while simultaneously addressing different dimensions of the target conditions. 23
Dashamoola's Core Pharmacological Mechanisms
What the Research Says
The foundational pharmacological validation of Dashamoola as a combination was published in the Journal of Ayurveda and Integrative Medicine (Parekar et al. 2015, PMC4395922). The study used commercially available standardised Dashamoolarishta prepared per Ayurvedic Pharmacopoeia methods, tested in Wistar albino rats (180–200 g) and Swiss albino mice (20–25 g). Five groups were compared: distilled water (control), aspirin (500 mg/kg), Dashamoolarishta alone, and Dashamoolarishta with aspirin. 2
The results across three validated experimental models were significant. In the acetic acid writhing test (visceral analgesia model): Dashamoolarishta alone and in combination with aspirin showed significantly fewer writhing responses (p<0.01) versus control. In the carrageenan-induced paw oedema model (acute inflammation): Dashamoolarishta produced significant paw oedema reduction (p<0.001) and significant reduction in peritoneal fluid proteins (p<0.001). In the cotton pellet granuloma model (chronic inflammation): significant reduction in granuloma weight (p<0.05). Anti-platelet activity: Dashamoola Kwath alone and in combination with aspirin significantly inhibited maximum platelet aggregation and percent inhibition of platelets (p<0.001). All effects were comparable to the aspirin reference group. Critically, the combination with aspirin did not produce additive adverse effects, suggesting complementary rather than duplicative mechanisms — the formula's prostaglandin pathway inhibition appears to complement rather than compete with aspirin's mechanism, consistent with the formula's multi-target pharmacological profile.
A clinical study published in the World Journal of Pharmaceutical Research (Vol. 11, Issue 5, 2022) by Siddhali et al. evaluated Dashamula Kwatha as an analgesic in Sutika Awastha (postpartum state), enrolling 50 patients from a teaching hospital in Pune irrespective of parity (Caesarean section patients excluded). 4 Four distinct types of postpartum pain were assessed: episiotomy pain, after-pains (uterine cramping), backache, and generalised body ache — all measured using the Visual Analogue Scale (VAS) on days 1–5 during inpatient stay and at day 10 post-delivery. Dashamula Kwatha was administered 20 ml orally twice daily with equal lukewarm water from day of parturition to day 10.
The study reported clinically significant reductions in VAS pain scores across all four pain types through the treatment period. The mechanistic rationale in the paper is precise: postpartum pain involves multiple components — episiotomy wound inflammation (prostaglandin-mediated), uterine smooth muscle cramping (after-pains via oxytocin and prostaglandins), musculoskeletal pain from labour exertion (inflammatory and mechanical), and generalised Vata aggravation from the profound tissue depletion of childbirth. Dashamoola's multi-root formula addresses each component simultaneously: the anti-inflammatory prostaglandin inhibition from Shyonaka and Patala flavonoids manages episiotomy and uterine pain; the nervine-restorative action of Shalaparni and Prishnaparni addresses the musculoskeletal component; Gokshura's diuretic function facilitates Kleda (excess fluid) clearance; and Gambhari's Rasayana action begins the tissue regeneration process. The study concluded Dashamula can be "the best drug of choice in Sutika Awastha Shula."
A network pharmacology analysis published in ScienceDirect (Kumar RCS et al. 2025, cited as "Deciphering the molecular mechanisms of Dashamoola: A network pharmacology approach") applied the methodology of systems pharmacology — used extensively to reverse-engineer TCM formulas — to Dashamoola for the first time, mapping the formula's compounds against inflammatory and pain pathway protein interaction networks. 3
Network pharmacology analysis constructs molecular relationship networks between phytochemicals and their known biological targets, then overlays these against disease pathway gene networks, identifying key "hub" proteins where the formula's compounds produce pharmacological leverage. The analysis confirmed that Dashamoola's ten roots collectively engage a broader inflammatory pathway network than any individual root, with key targets including TNF-α, interleukins (IL-1β, IL-6), COX-1/COX-2, and neural pain transmission nodes. The formula's network structure demonstrates "one arrow, multiple targets" architecture — the same principle that makes pharmaceutical multi-target drugs superior to single-target drugs for complex, multi-pathway conditions like chronic inflammation and neurological pain. The individual roots' flavonoids (Shyonaka, Patala), alkaloids (Kantakari, Brihati), saponins (Gokshura), terpenoids (Bilva), and polyphenols (Gambhari) collectively contribute distinct compound classes to different molecular targets within the shared inflammatory network.
A comprehensive review published in the Journal of Ayurveda and Integrated Medical Sciences (2025) specifically examined Dashamoola's therapeutic applications in Stri Roga (women's health conditions), reviewing its pharmacological attributes, historical applications, and contemporary scientific validation across menstrual health, pregnancy, postpartum care, and reproductive wellness. 5
The review confirmed that the formula's botanical components — particularly Shalaparni, Prishnaparni, and Gokshura — have significant anti-inflammatory, analgesic, and adaptogenic characteristics that specifically address the neuro-hormonal, musculoskeletal, and inflammatory dimensions of gynaecological conditions. The review detailed applications across: menstrual irregularities (Vata-type amenorrhoea, dysmenorrhoea — the uterine smooth muscle-relaxing and prostaglandin-inhibiting mechanism); difficult periods; heavy menstrual bleeding; infertility (the nervine-reproductive axis); pregnancy-related musculoskeletal conditions; postpartum recovery (the primary application, validated by the 50-patient clinical study); and menopausal symptoms (Vata-Pitta aggravation that Dashamoola's Tridoshahara property addresses). The review also documented Dashamoola Taila — the oil preparation used for uterine Nasya, Basti, and external massage — as a distinct application format for obstetric and gynaecological Vata management, separate from the oral Kwatha preparation.
Beyond the whole-formula studies, each of Dashamoola's ten roots has independent pharmacological evidence that validates its role in the formula's classical therapeutic design. 6 Key validated root activities include: Gokshura (Tribulus terrestris) — one of the most extensively studied Ayurvedic roots globally, with confirmed diuretic, anti-inflammatory, saponin-mediated testosterone/testosterone precursor (furostanol saponins), and nephroprotective activities in multiple RCTs and meta-analyses; Kantakari (Solanum xanthocarpum) — confirmed bronchodilatory activity via glycoalkaloids, validated in respiratory pharmacology studies, with caffeic acid and phenolic content variation across growing regions documented (Saxena et al., Clin Phytosci 2021); Gambhari (Gmelina arborea) — confirmed immunomodulatory and hematopoietic properties; Rasayana classification validated by antioxidant and tissue-building activities; Shyonaka (Oroxylum indicum) — oroxylin A and baicalein flavonoids confirmed as potent anti-inflammatory and antioxidant compounds; Bilva (Aegle marmelos) — sacred bael tree; well-documented anti-diarrhoeal, gastroprotective, and anti-inflammatory applications in both Ayurvedic and conventional pharmacology; Shalaparni (Desmodium gangeticum) and Prishnaparni (Uraria picta) — Laghu Panchamoola nervine tonics with confirmed adaptogenic and anti-inflammatory activities in animal models. Together these ten independent pharmacological profiles validate Charaka's formula design from the bottom up.
Clinical Evidence at a Glance
Classical Preparations of Dashamoola
Dashamoola exists in multiple preparation forms in classical Ayurveda, each with different onset, depth of action, and clinical application. The choice of preparation form is as important as the formula itself — the classical Ayurvedic pharmacist's distinction between Kwatha, Arishta, Taila, and Ghrita preparations reflects real differences in which compounds are extracted, their bioavailability, and the system of administration.
| Preparation | Description | Primary Applications |
|---|---|---|
| Dashamoola Kwatha (Decoction) | Classical water decoction of equal parts of all ten roots (10–12 g per 200 ml, reduced to 50 ml); taken warm on an empty stomach; the most fundamental preparation; used in the postpartum clinical study at 20 ml twice daily | Postpartum recovery; acute joint pain and arthritis; fever; respiratory conditions; general Vata pacification; Panchakarma preparatory; short-term intensive treatment |
| Dashamoolarishta (Fermented) | Fermented decoction preparation; the Kwatha base is fermented with jaggery or sugar and added herbs; 5–15% alcohol content enhances extraction of lipid-soluble compounds; longer shelf life; gentle onset; the preparation tested in the Parekar et al. pharmacological study | Chronic Vata disorders; long-term arthritis and rheumatic conditions; chronic respiratory conditions; the standard daily tonic form; 15–30 ml with equal water after meals; the most widely commercially available Dashamoola preparation |
| Dashamoola Taila (Oil) | Sesame oil base processed with Dashamoola decoction and paste; applied externally; the classical Brhimhana (nourishing) external therapy for deep Vata tissue penetration; also used as Nasya (nasal) oil for cervical spondylosis and neuromuscular conditions | External Abhyanga (oil massage) for arthritis, joint pain, cervical spondylosis, neuropathy, and postpartum body massage; Panchakarma Abhyanga base oil; Nasya for cervical and cranial Vata; Kati Basti (warm oil pool for lower back) |
| Dashamoola Ghrita (Medicated Ghee) | Clarified butter processed with Dashamoola; the deepest-acting preparation for neurological and chronic Vata conditions; ghee base carries active compounds into the deepest tissue layers (Majja — bone marrow and nerve) | Deep neurological Vata conditions — neuropathy, neuralgia, sciatica; osteoarthritis with bone wasting; chronic postpartum recovery; long-term Vata Rasayana; 5–10 g daily with warm milk |
| Niruha Basti (Therapeutic Enema) | Dashamoola Kwatha used as the base for Niruha Basti — the primary Vata-pacifying Panchakarma therapy; the decoction enema is absorbed directly from the colon (the seat of Vata) into systemic circulation; the most direct route for Vata pacification in Ayurvedic medicine | The most potent classical Vata-treatment method; used in Panchakarma for severe arthritis, sciatica, neurological conditions, paralysis, and chronic pain syndromes; administered under clinical supervision in graduated Basti protocols (Karma Basti: 30 sessions; Kala Basti: 16 sessions; Yoga Basti: 8 sessions) |
Supaveda Products with Dashamoola
Dashamoola provides the master Vata-pacifying formula dimension across Supaveda's joint and daily tonic products:
SupaJoints brings together Ayurveda's two complementary anti-inflammatory approaches: the single-herb precision of targeted pharmacological compounds (Shallaki's AKBA for 5-LOX inhibition, Haridra's curcumin for NF-κB and COX-2 suppression) alongside the multi-herb systems coverage of Dashamoola's Tridoshahara formula. Where the individual herbs address specific molecular inflammatory targets, Dashamoola addresses the root cause in Ayurvedic terms — the Vata aggravation that drives the cold, dry, degenerative dimension of joint disease that anti-inflammatory single compounds do not reach. Together they cover both the acute inflammatory dimension (single-herb pathways) and the Vata-degenerative-pain dimension (Dashamoola's ten-root network) — a genuinely comprehensive joint support approach that mirrors how classical Ayurvedic physicians designed their compound joint formulas. Sunthi (Trikatu) ensures bioavailability of all active compounds.
In the classical Chyawanprash tradition, Dashamoola provides the systemic Vata-pacifying scaffold — the formula that keeps the nervous system, musculoskeletal system, and respiratory channels in the balanced, fluid, nourished state that allows all the Rasayana herbs to perform their long-term tissue-building work. Without managing Vata — the moving, drying, degenerating force — no Rasayana can fully accomplish its restorative action. Dashamoola in Supa Life is therefore both an active multi-system anti-inflammatory and the structural foundation that makes the whole formula's Rasayana action more effective: Amla builds immunity and antioxidant capacity; Bhringaraj regenerates hair and liver; Ashwagandha reduces cortisol and builds resilience; Haridra reduces inflammation — and Dashamoola holds the entire edifice in Vata-pacified equilibrium, the ten-root foundation of the classical Ayurvedic longevity formula.
Safety & Precautions
Dashamoola has been used continuously across South Asian traditional medicine systems for over three millennia with an established safety profile. The pharmacological study (Parekar et al.) confirmed that Dashamoola formulations combined with aspirin did not produce additive adverse effects beyond those of aspirin alone — suggesting the formula's mechanisms are complementary rather than duplicative at standard doses. All ten constituent roots are accepted food-grade or well-tolerated medicinal plants with extensive traditional use records.
Please Note
- Pregnancy (first and second trimester): The formula has strong Vata-mobilising and Ushna (heating) properties in nine of ten roots. While it is the classical postpartum formula, it is not recommended during pregnancy without professional Ayurvedic supervision — particularly in the first trimester, where Vata mobilisation and uterine stimulation are contraindicated. Specific preparations (Dashamoola Taila, Basti) during pregnancy require clinical oversight.
- Anticoagulant medications: The confirmed anti-platelet activity of Dashamoola (significant inhibition of platelet aggregation, p<0.001) means those on warfarin, aspirin, clopidogrel, or other anticoagulants should inform their prescribing physician before regular Dashamoola supplementation, as additive anti-platelet effects are pharmacologically expected.
- Pitta-dominant constitutions at high doses: Nine of ten roots are heating (Ushna Virya). At high doses or over extended use without appropriate management, those with significant Pitta excess (active acid reflux, inflammation, skin rashes, fever) may experience Pitta aggravation. Dashamoolarishta (fermented preparation) is generally better tolerated in such cases due to its moderate alcohol fermentation buffering the heating properties.
- Gokshura and kidney conditions: The diuretic saponins in Gokshura root are active. Those with known renal disease should inform their nephrologist before beginning Dashamoola supplementation; increased urine output is expected and not harmful in most contexts but requires monitoring in kidney disease.
- Botanical identity verification: The Dashamoola formula's quality depends critically on correct botanical identification of all ten roots. Commercial adulteration (particularly substitution of Agnimantha and Shalaparni species) is documented. Sourcing from suppliers with verified botanical authentication (HPTLC or DNA barcoding) is strongly recommended for therapeutic-dose supplementation.
Key Takeaways
Evidence-backed points:
Ayurveda's first-ever anti-inflammatory formula: Charaka Samhita classifies Dashamoola under Shvayathuhara Gana — the inflammation-reducing group — designating it Shothe Dashamoola: the drug of choice for swelling and inflammation. Three millennia before aspirin, classical physicians designed a ten-root anti-inflammatory team covering every dimension of inflammatory disease
Anti-inflammatory, analgesic, and anti-platelet comparable to aspirin in validated experimental models — paw oedema reduction (p<0.001), visceral analgesia (p<0.01), platelet aggregation inhibition (p<0.001) — tested as the combination formula, as it was designed to be used (Parekar et al. 2015, PMC4395922)
The classical postpartum gold standard: Dashamoola Kwatha is the first medicine given to every new mother in traditional Ayurvedic practice — the formula that simultaneously manages postpartum pain, supports uterine involution, and begins tissue regeneration after childbirth. Clinical study of 50 patients (Siddhali et al. 2022) confirmed significant VAS pain reduction across all four postpartum pain types
Formula intelligence validated by network pharmacology: 2025 molecular network analysis confirmed Dashamoola's ten roots collectively target a broader inflammatory pathway network than any individual root — computational proof of the classical claim that the combination produces emergent therapeutic properties that no single herb achieves
The only Tridoshahara anti-inflammatory formula: nine roots with Ushna (heating) potency counter Vata's cold quality; one root — Gokshura — is Sheeta (cooling), tempering the formula to prevent Pitta aggravation. This single counterbalancing root is a masterclass in Ayurvedic formula design: ten herbs, one formula, three doshas balanced
Two-tier formula architecture: Brihat Panchamoola (5 large tree/shrub roots) for structural/grounding Vata in bones, joints, muscles; Laghu Panchamoola (5 small plant roots) for functional/penetrating Vata in nerves, airways, fluid channels. The combination spans the full anatomical range of Vata's domain
Kantakari + Brihati — the respiratory team: Kantakari (Solanum xanthocarpum) glycoalkaloid bronchodilator + Brihati (Solanum indicum) expectorant; 15% PEFR improvement in 30 asthma patients (Kerala trial); the pharmacological basis for Dashamoola's classical use in asthma and chronic cough alongside its primary anti-inflammatory applications
Five preparation forms, five depths of action: Kwatha (water decoction, acute), Arishta (fermented, chronic), Taila (oil, topical-deep tissue), Ghrita (ghee, deepest neurological), Basti (enema, the most powerful Vata treatment in Panchakarma). The same formula, five different vehicles, five different depths of therapeutic reach
Well-tolerated with millennia of traditional use; combination with aspirin did not produce additive adverse effects in pharmacological study. Key precautions: avoid high doses in first/second trimester of pregnancy; inform doctor if on anticoagulants; verify botanical identity in commercial preparations; monitor Pitta-dominant constitutions for heating effects at high doses
References
- Classical Ayurvedic sources: Charaka Samhita, Sutrasthana, Svayathuhara Gana classification — Dashamoola as drug of choice for Shotha (Shothe Dashamoola); Sushruta Samhita; Ashtanga Hridayam; Sahasrayogam (primary text for Dashamoola Kwatha Choorna, confirmed as source in IJPSR 2022 standardisation study); Sharangdhara Samhita; Vimana Sthana earliest reference — Vata and tridosha balancing. Also: IJPSR 2022 standardisation study: botanical identification confirmed — Bilva (Aegle marmelos), Patala (Stereospermum suaveolens), Agnimantha (Clerodendrum phlomidis), Shyonaka (Oroxylum indicum), Gambhari (Gmelina arborea), Bruhati (Solanum nigrum), Gokshura (Tribulus terrestris), Kantakari (Solanum xanthocarpum), Prishnaparni (Uraria picta), Shalaparni (Desmodium gangeticum); WHO guideline physico-chemical standardisation; HPTLC conducted. Also: Parekar et al. Charaka Samhita reference for Gana classification; JAIMS 2022 anti-inflammatory review; WisdomLib Shvayathuhara Gana commentary.
- Parekar, R.R., Bolegave, S.S., Marathe, P.A. and Rege, N.N. (2015) 'Experimental evaluation of analgesic, anti-inflammatory and anti-platelet potential of Dashamoola', Journal of Ayurveda and Integrative Medicine, 6, p.11. PMC4395922. [Wistar albino rats 180–200 g, Swiss albino mice 20–25 g; 5 groups — control, aspirin, Dashamoolarishta, combination; commercially available standard Dashamoolarishta per Ayurvedic Pharmacopoeia; acetic acid writhing test: significant fewer writhes p<0.01; carrageenan paw oedema: significant reduction p<0.001; peritoneal proteins: p<0.001; cotton pellet granuloma: p<0.05; platelet aggregation: significant inhibition p<0.001; effects comparable to aspirin; combination with aspirin showed complementary not additive adverse effects; prostaglandin synthesis inhibition proposed as primary mechanism; "Dashamoola has consistently shown efficacy in models of acute inflammation"].
- Kumar, R.C.S. et al. (2025) 'Deciphering the molecular mechanisms of Dashamoola: a network pharmacology approach', ScienceDirect. [Network pharmacology analysis; phytochemical-target-pathway network mapping; inflammatory pathway nodes — TNF-α, IL-1β, IL-6, COX-1/COX-2; neural pain transmission targets; ten roots collectively cover broader target network than individual roots; multi-target "one arrow multiple targets" architecture validated computationally; confirms formula synergism as emergent property of combination]. Also: Urs R et al. (2022) 'Conceptual understanding of the anti-inflammatory effects of Dashamoola with relevant modern perspective', JAIMS 7(11):156 [alkaloids suppress IL-1, NK cell cytotoxicity, mast cell histamine, PAF; tannic acid anti-inflammatory polyphenol mechanism; Shopha classical signs mapped to dosha involvement].
- Siddhali, P. et al. (2022) 'Clinical study on the efficacy of Dashamula Kwatha as an analgesic in Sutika Awastha Shula', World Journal of Pharmaceutical Research, 11(5). [50 postpartum patients; parity-inclusive; Caesarean excluded; 4 pain types: episiotomy, after-pains, backache, body ache; VAS scale assessment days 1–5 IPD and day 10; 20 ml Dashamula Kwatha orally twice daily with lukewarm water; significant VAS reduction across all pain types at days 1–5 and day 10; "Dashamula can be best drug of choice in Sutika Awastha Shula"; mechanistic explanation: prostaglandin inhibition for episiotomy/after-pains; nervine action for musculoskeletal pain; diuretic Kleda clearance; Gambhari Rasayana for tissue regeneration; Tridoshahara property addresses profound Vata aggravation of childbirth]. Also: Dashmoola in Stri Roga review, JAIMS 2025 — menstrual irregularities, pregnancy, postpartum, menopausal applications; Dashamoola Taila Nasya and Basti applications for obstetric Vata management.
- JAIMS (2025) 'Dashmoola in Stri Roga: a review on its therapeutic benefits', Journal of Ayurveda and Integrated Medical Sciences. [Comprehensive gynaecological review; Shalaparni, Prishnaparni adaptogenic; Gokshura diuretic; anti-inflammatory, analgesic, adaptogenic characteristics for Stri Roga; menstrual irregularities, heavy bleeding, infertility, pregnancy-related issues, postpartum recovery, menopausal symptoms; Dashamoola Taila uterine Nasya/Basti applications; citation of 50-patient postpartum clinical study; Saxena et al. 2021 phenolic content Kantakari variation across growing regions].
- Anantya Healthcare (2025) 'Dashamoola Kwath: a comprehensive guide'. Also: EasyAyurveda (2024) 'Dashamoola: Shothahara Mahakashay'. Also: ScienceDirect (2020) 'Phytochemical rich extract from spent material of industrial Dashamoola preparation — antioxidant, antidiabetic and anti-inflammatory potential' (Sahasrayogam source confirmed; HPTLC characterisation; antioxidant and anti-inflammatory activity of combined spent extract confirmed). Individual root actions: Bilva — gut-soothing, gastroprotective, anti-diarrhoeal; Agnimantha — Deepana-Pachana, digestive fire; Shyonaka — oroxylin A and baicalein flavonoids, COX-2 inhibition; Patala — circulation, muscle stiffness; Gambhari — immunomodulatory, hematopoietic, Rasayana; Brihati — expectorant, decongestant, glycoalkaloids; Kantakari — bronchodilator, anti-asthmatic, caffeic acid phenolics (Saxena et al. Clin Phytosci 2021); Shalaparni — nervine stabiliser, adaptogenic; Prishnaparni — nervine tonic, restorative; Gokshura — diuretic saponins (protodioscin), nephroprotective, Sheeta Virya unique cooling property. Kerala asthma trial 2018: 30 mild asthma patients, 15% PEFR improvement with Dashamoola Kashayam, chest tightness relief.